{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:38:24Z","timestamp":1754145504701,"version":"3.41.2"},"reference-count":26,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Head &amp; Neck"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>Full\u2010dose postoperative external beam radiation therapy (EBRT)\/chemoradiation is the standard of care in patients with resected, unirradiated head and neck cancer (HNC). This study aims to determine the long\u2010term results of adjuvant high\u2010dose rate (HDR) brachytherapy\u2009\u00b1\u2009intermediate\u2010dose postoperative external beam radiation therapy (EBRT)\/chemoradiation in this HNC patient population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>From 2000 to 2018, a total of 152 patients diagnosed with HNC were treated with surgery and adjuvant HDR brachytherapy alone (<jats:italic>n<\/jats:italic>\u2009=\u200932) or combined with EBRT\u2009\u00b1\u2009chemotherapy (<jats:italic>n<\/jats:italic>\u2009=\u2009120). Patients treated with brachytherapy alone received 32 or 40\u2009Gy in 8 or 10\u2009b.i.d. fractions. Combined modality patients received 16 or 24\u2009Gy of HDR brachytherapy in 4\u20136 b.i.d. fractions followed by EBRT 45\u2009Gy in 25 fractions\u2009\u00b1\u2009chemotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Median follow\u2010up was 8.1\u2009years (range, 0.1\u201321.6). Forty patients (26.3%) developed RTOG grade \u2265\u20093 adverse events, mainly soft tissue necrosis (11.2%) and osteoradionecrosis (6.6%). The 5\u2010year local and locoregional control rates were 85.5% and 74.9%, respectively. Five\u2010year disease\u2010free survival and overall survival rates were 54.9% and 62.2%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Adjuvant HDR brachytherapy alone or combined with EBRT is an adequate treatment option for HNC patients who are candidates to receive postoperative radiation\/chemoradiation. The results obtained in terms of toxicity and locoregional control are comparable to standard chemoradiation. In addition, this study identifies a subset of patients that may benefit from adjuvant HDR in terms of reduced toxicity, provided that the high\u2010risk CTV does not exceed 15\u2009cm<jats:sup>3<\/jats:sup> and is treated to EQD2\u2010DVH TV<jats:sub>100<\/jats:sub> doses of less than 87\u2009Gy, together with a mandible<jats:sub>2cm3<\/jats:sub> of less than 61\u2009Gy.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hed.28131","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T19:59:44Z","timestamp":1741723184000},"page":"2166-2173","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prospective Registry Trial of Adjuvant High\u2010Dose Rate Brachytherapy in Unirradiated Head and Neck Cancer: 20\u2010Year Data"],"prefix":"10.1002","volume":"47","author":[{"given":"Alejandro","family":"Garc\u00eda\u2010Consuegra","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology Cancer Center Cl\u00ednica Universidad de Navarra (CCUN)  Pamplona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gimeno\u2010Morales","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Cancer Center Cl\u00ednica Universidad de Navarra (CCUN)  Pamplona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Cambeiro","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Cancer Center Cl\u00ednica Universidad de Navarra (CCUN)  Pamplona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"L\u00f3pez\u2010Picazo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Cancer Center Cl\u00ednica Universidad de Navarra (CCUN)  Pamplona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Alcalde","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery Cancer Center Cl\u00ednica Universidad de Navarra (CCUN)  Pamplona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"I Ramos","sequence":"additional","affiliation":[{"name":"Medical Physics Department Hospital Universitario Arnau Vilanova  Lleida Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"UOC di Radiologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS  Roma Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Guinot","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fundaci\u00f3n IVO  Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bussu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Pharmacy, ENT Division University of Sassari  Sassari Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Moreno\u2010Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Cancer Center Cl\u00ednica Universidad de Navarra (CCUN)  Pamplona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-4816","authenticated-orcid":false,"given":"Rafael","family":"Martinez\u2010Monge","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Cancer Center Cl\u00ednica Universidad de Navarra (CCUN)  Pamplona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"National Comprehensive Cancer Network \u201cPractice Guidelines in Oncology \u201d 2024."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00717-7"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22648"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0748-7983(97)92484-7"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2005.11.003"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2006.12.001"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2006.06.012"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.1991.101.4.405"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-1-27"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)00417-4"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.5114\/jcb.2022.113425"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2008.10.002"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.08.023"},{"volume-title":"The GEC\u2010ESTRO Handbook of Brachytherapy","year":"2019","author":"Mart\u00ednez\u2010Monge R.","key":"e_1_2_7_16_1"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(95)01548-U"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.09.015"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032646"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.05.008"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032641"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20279"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00152-1"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.10377"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2020.10.008"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-59989670006-2"}],"container-title":["Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.28131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T02:32:48Z","timestamp":1752719568000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hed.28131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1002\/hed.28131"],"URL":"https:\/\/doi.org\/10.1002\/hed.28131","archive":["Portico"],"relation":{},"ISSN":["1043-3074","1097-0347"],"issn-type":[{"type":"print","value":"1043-3074"},{"type":"electronic","value":"1097-0347"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"2025-01-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}